15-059
Showing 1 - 25 of >10,000
Allergic Bronchopulmonary Aspergillosis Trial in Manchester (Voriconazole inhaled, oral voriconazole)
Completed
- Allergic Bronchopulmonary Aspergillosis
- Voriconazole inhaled
- oral voriconazole
-
Manchester, United KingdomMedicines Evaluation Unit Ltd. (MEU)
Nov 12, 2021
Hepatitis B Trial (Modified Process Hepatitis B Vaccine)
Completed
- Hepatitis B
- Modified Process Hepatitis B Vaccine
- (no location specified)
Aug 19, 2022
Type 2 Diabetes Trial in Worldwide (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +4 more
-
Birmingham, Alabama
- +99 more
Nov 25, 2022
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )
Recruiting
- Systemic Lupus Erythematosus (SLE)
- BIIB059
- BIIB059-matching placebo
-
Mesa, Arizona
- +280 more
Jul 20, 2022
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR
Active, not recruiting
- Leukemia
- KIR genotyping
- HLA genotyping
-
Tampa, Florida
- +9 more
Nov 29, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- pembrolizumab
- +3 more
- (no location specified)
Jul 13, 2022
Osteoarthritis, Knee Trial in Worldwide (Diclofenac Sodium Gel 1%, Voltaren Gel, Placebo)
Completed
- Osteoarthritis, Knee
- Diclofenac Sodium Gel 1%
- +2 more
-
Paide, Estonia
- +50 more
Feb 25, 2021
Research on Construction of Cord Blood Storage Decision Aid
Recruiting
- Pregnant Women
-
Jinan, ChinaZhongguo
Aug 15, 2023
Chorioretinopathy, Central Serous Trial in Shiraz (Crocin, Placebo)
Recruiting
- Chorioretinopathy, Central Serous
- Crocin
- Placebo
-
Shiraz, Fars, Iran, Islamic Republic ofShiraz University of Medical Sciences
Oct 27, 2021
Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin, Placebo)
Completed
- Adjunctive Treatment of Major Depressive Disorder
- Pimavanserin
- Placebo
-
Birmingham, Alabama
- +84 more
Oct 19, 2021
Lupus Erythematosus, Systemic Trial in Worldwide (BIIB059, BIIB059 matching )
Recruiting
- Lupus Erythematosus, Systemic
- BIIB059
- BIIB059 matching placebo
-
Upland, California
- +41 more
Apr 19, 2022
Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)
Not yet recruiting
- Graves' Disease
- Mycophenolate Mofetil, Oral, 250 Mg
- methimazole, oral, 10mg
- (no location specified)
Sep 28, 2023
Diet, Food, and Nutrition Trial in Liverpool (Experimental: Consumption of three different doses of hydrolyzed collagen (HC)
Completed
- Diet, Food, and Nutrition
- Experimental: Consumption of three different doses of hydrolyzed collagen (HC) with reistance exercise
- Experimental: Consumption of two different doses of hydrolyzed collagen (HC) with reistance exercise
-
Liverpool, United KingdomDr Rob Erskine
Jun 27, 2023
Bile Duct Diseases Trial in Dallas (ERCP with NvisionVLE® Imaging Low Profile System)
Completed
- Bile Duct Diseases
- ERCP with NvisionVLE® Imaging Low Profile System
-
Dallas, TexasMethodist Health System
Feb 21, 2022
COVID-19 Respiratory Infection Trial in Lublin (Xanthohumol - prenylated chalcone extracted from female inflorescences of hop
Suspended
- COVID-19 Respiratory Infection
- Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/
-
Lublin, PolandMedical University of Lublin
Jul 15, 2022
Quality of Life and Disease-related Symptoms in Individuals With
Not yet recruiting
- Mastocytosis, Systemic
- No intervention
-
Stockholm, Sweden
- +1 more
Sep 26, 2023
Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)
Recruiting
- Endometriosis
- Unexplained Infertility
- Elagolix
- Oral Contraceptive
-
Winston-Salem, North CarolinaWake Forest Univesity Health Sciences
Dec 1, 2022
Sarcopenia Trial (Whey postbiotics derived from kefir lactic acid bacteria, Placebo powder)
Not yet recruiting
- Sarcopenia
- Whey postbiotics derived from kefir lactic acid bacteria
- Placebo powder
- (no location specified)
Nov 21, 2023
Coronary Disease Trial (MK0653, ezetimibe / Duration of Treatment: 27 Weeks, MK0733, simvastatin / Duration of Treatment: 27
Completed
- Coronary Disease
- MK0653, ezetimibe / Duration of Treatment: 27 Weeks
- +2 more
- (no location specified)
Feb 7, 2022
Rheumatoid Arthritis Trial (Natrunix with MTX (+folate), Natrunix with MTX (+folate))
Not yet recruiting
- Rheumatoid Arthritis
- Natrunix with MTX placebo (+folate)
- Natrunix placebo with MTX (+folate)
- (no location specified)
May 2, 2022
Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee Trial in United States (Cebranopadol (GRT6005) Low-Dose Range,
Completed
- Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
- Cebranopadol (GRT6005) Low-Dose Range
- +3 more
-
Birmingham, Alabama
- +82 more
Jul 13, 2021
Acute Heart Failure Trial in Ho Chi Minh City (Tolvaptan 15 MG)
Recruiting
- Acute Heart Failure
- Tolvaptan 15 MG
-
Ho Chi Minh City, VietnamCardiology Department
Aug 9, 2022
Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)
Recruiting
- Colorectal Cancer
- +2 more
- Sanprobi IBS®
-
Kościerzyna, PolandUnit of Surgery with Unit of Oncological Surgery in Koscierzyna
Aug 24, 2023
Off-the-shelf Single REnal Scalloped sTent-graft for HOstile
Recruiting
- Abdominal Aortic Aneurysm
- Endovascular Aortic Repair (EVAR)
-
Baggiovara, Modena, ItalyAOU di Modena
Jan 30, 2023